company background image
X2S1 logo

Sinopharm Group DB:X2S1 Stock Report

Last Price

€12.60

Market Cap

€7.8b

7D

3.3%

1Y

16.7%

Updated

07 Dec, 2024

Data

Company Financials +

X2S1 Stock Overview

Engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People’s Republic of China. More details

X2S1 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance2/6
Financial Health5/6
Dividends5/6

Sinopharm Group Co. Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sinopharm Group
Historical stock prices
Current Share PriceHK$12.60
52 Week HighHK$13.50
52 Week LowHK$9.15
Beta0.85
11 Month Change5.00%
3 Month Change32.63%
1 Year Change16.67%
33 Year Change38.46%
5 Year Changen/a
Change since IPO29.71%

Recent News & Updates

Recent updates

Shareholder Returns

X2S1DE HealthcareDE Market
7D3.3%4.2%3.2%
1Y16.7%18.3%9.7%

Return vs Industry: X2S1 underperformed the German Healthcare industry which returned 18.3% over the past year.

Return vs Market: X2S1 exceeded the German Market which returned 9.7% over the past year.

Price Volatility

Is X2S1's price volatile compared to industry and market?
X2S1 volatility
X2S1 Average Weekly Movement6.0%
Healthcare Industry Average Movement4.2%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.5%
10% least volatile stocks in DE Market2.4%

Stable Share Price: X2S1 has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: X2S1's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2003113,635Wanyong Lianwww.sinopharmgroup.com.cn

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People’s Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics.

Sinopharm Group Co. Ltd. Fundamentals Summary

How do Sinopharm Group's earnings and revenue compare to its market cap?
X2S1 fundamental statistics
Market cap€7.80b
Earnings (TTM)€1.13b
Revenue (TTM)€76.88b

6.9x

P/E Ratio

0.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
X2S1 income statement (TTM)
RevenueCN¥590.35b
Cost of RevenueCN¥543.16b
Gross ProfitCN¥47.18b
Other ExpensesCN¥38.53b
EarningsCN¥8.65b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)2.77
Gross Margin7.99%
Net Profit Margin1.47%
Debt/Equity Ratio78.1%

How did X2S1 perform over the long term?

See historical performance and comparison

Dividends

4.5%

Current Dividend Yield

31%

Payout Ratio